Iclusig (ponatinib) - Important Safety Information from Ariad Pharma Ltd. as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 09/12/2013

 

Problem Or Issue:
Important Safety Information communication from Ariad Pharma Ltd. on the risk of vascular occlusive events with Iclusig (ponatinib).   

Important Safety Information ­- Iclusig (ponatinib)


« Back